Inspire Medical Systems CFO to step down in December

Inspire Medical Systems Inc. (NYSE: INSP) announced that Chief Financial Officer Rick Buchholz will step down from his position effective December 31, 2025, to pursue other professional opportunities.

Buchholz, who joined the medical technology company in 2014, will remain with Inspire in a financial advisory role through February 28, 2026, to facilitate the transition. The company has initiated a search for his replacement.

"Since joining Inspire in 2014, Rick has provided steady leadership and invaluable guidance, leaving a lasting impact on the company," said Tim Herbert, Chairman and Chief Executive Officer. Herbert noted Buchholz's role during the company's growth from $4 million in revenue to over $800 million in 2024.

The Minneapolis-based company develops minimally invasive solutions for patients with obstructive sleep apnea. Its Inspire therapy is described as the first FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.

Inspire reaffirmed its 2025 financial guidance, projecting revenue of $900 million to $910 million, gross margins of 84% to 86%, and diluted net income per share of $0.40 to $0.50.

The information is based on a company press release.

You May Also Be Interested In

• Marvell names Dan Durn as CFO effective June 15, 2026
• Vivos Therapeutics plans rights offering to raise capital
• Rocket One adds former NASA astronaut Kimbrough to advisory board